A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples